Department of Radiation Oncology(NCKUH)

Medicine & Life Sciences

1. Head and Neck Neoplasms 100%
2. Survival 55%
3. Esophageal Squamous Cell Carcinoma 48%
4. Radiotherapy 44%
5. Chemoradiotherapy 41%
6. Neoplasms 34%
7. Radiation 27%
8. Squamous Cell Carcinoma 24%
9. Intensity-Modulated Radiotherapy 23%
10. Alcohols 23%
11. Nasopharyngeal Carcinoma 20%
12. Drug Therapy 20%
13. Alcohol Drinking 18%
14. Triple Negative Breast Neoplasms 17%
15. Neck 17%
16. Copper Transporter 1 16%
17. Hypopharyngeal Neoplasms 16%
18. Oropharyngeal Neoplasms 15%
19. Platinum 15%
20. Fluorodeoxyglucose F18 15%
21. Confidence Intervals 15%
22. Mouth 14%
23. Catenins 12%
24. Odds Ratio 12%
25. Genetic Polymorphisms 12%
26. Therapeutics 12%
27. Positron Emission Tomography Computed Tomography 11%
28. Mouth Neoplasms 10%
29. Tobacco Products 10%
30. Carcinogenesis 10%
31. Life Style 10%
32. Glioblastoma 9%
33. Serum 9%
34. Non-Small Cell Lung Carcinoma 8%
35. Stomach Neoplasms 8%
36. Hypersensitivity 8%
37. MicroRNAs 7%
38. Hepatocellular Carcinoma 7%
39. Nasopharyngeal Neoplasms 7%
40. Metal Nanoparticles 7%
41. Adjuvant Chemoradiotherapy 7%
42. Temozolomide 7%
43. Monocrotaline 7%
44. Esophageal Fistula 6%
45. Anaplastic Thyroid Carcinoma 6%
46. Lymph Nodes 6%
47. Cell Plasticity 6%
48. Adjuvant Chemotherapy 6%
49. Keloid 6%
50. Genes 6%
51. Pharmaceutical Preparations 6%
52. Registries 6%
53. Drug and Narcotic Control 6%
54. Endosonography 6%
55. Papillomaviridae 6%
56. Prealbumin 6%
57. Sorafenib 6%
58. Stem Cells 5%
59. Nomograms 5%
60. Osteopontin 5%
61. Tomography 5%
62. Pericardial Effusion 5%
63. Pulmonary Arterial Hypertension 5%
64. Human papillomavirus 16 5%
65. Reactive Oxygen Species 5%
66. Down-Regulation 5%
67. Neoadjuvant Therapy 5%
68. Vegetables 5%
69. Survival Rate 5%
70. Genotype 5%
71. Endometrial Neoplasms 5%
72. Squamous Cell Carcinoma of Head and Neck 5%
73. Radiosurgery 5%
74. Dermatitis 5%
75. Inferior Vena Cava 5%
76. Tumor Burden 5%
77. Long Noncoding RNA 5%
78. Cyclin D1 5%
79. Zinc 5%
80. Transferrin 5%
81. Antineoplastic Agents 5%
82. Interleukin-17 5%
83. Vitamin A 5%
84. Multiple Drug Resistance 5%